DUBAI: National Health Regulatory Authority (NHRA) of Bahrain Sunday approved the use of China-based Sinopharm’s COVID-19 vaccine in the country. The approval follows the success of Sinopharm’s clinical trials across several countries, where Phase III results showed an 86 percent efficacy rate on 42,299 volunteers. The NHRA thoroughly reviewed the data behind the Chinese-made vaccine,…